In MPS VI rats, treatment with infliximab prevented the elevation of TNF-α and NF-kB signaling not only in the blood but also in articular chondrocytes and fibroblast-like synoviocytes [35]. Here, TNF is linked to mucopolysaccharidosis type 6.